Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5+
SponsorUwemedimo Friday Ekpo

About this trial

Neglected Tropical Diseases (NTDs) are among the most common groups of diseases affecting over one billion people globally and are disproportionately concentrated in remote, underserved, and marginalized communities. Efforts toward NTD elimination have largely relied on preventive chemotherapy (PC), large-scale distribution of free, safe, and effective medicines to at-risk populations. One major challenge threatening elimination efforts is the poor participation of mobile and migrant populations (MMPs) in treatment programs. Despite this gap, few studies have explored strategies to improve access among these underserved populations.

This study aims to determine the burden of NTDs among MMPs and explore strategies for expanding access to preventive chemotherapy through social and occupational networks using community mapping and participatory action research approaches in Nigeria.

This project is a multi-site implementation research study involving 15 communities across three Nigerian states-Taraba, Akwa Ibom, and Ondo-representing pastoralist, fishing, and agrarian settings, respectively. The study comprises four phases. The first two formative phases will assess the baseline burden of NTDs and coverage of preventive chemotherapy interventions using community surveys, parasitological and serological assessments, mapping, and participatory workshops to identify migration patterns, anchor points, and social and occupational networks that could support expansion of PC. The third phase will use participatory approaches to co-construct context-specific strategies for expanding access to preventive chemotherapy among MMPs. In the fourth phase, the co-developed strategies will be implemented and evaluated for impact using established implementation research frameworks and mixed methods approaches.

Through this project, investigators will develop and evaluate a novel strategy for expanding access to PC among MMPs. The study will generate evidence on the feasibility, acceptability, reach, and sustainability of the proposed approach and is expected to inform adaptable implementation models for inclusive NTD programming in Nigeria and similar endemic settings.

Eligibility criteria

Qualifiers

Are children aged 5-14 years or adult heads of households residing in households identified as belonging to mobile or migrant populations.

Reside permanently or semi-permanently within the study communities

Have missed one or more previous rounds of onchocerciasis and/or lymphatic filariasis MDA.

Are willing to provide the required biological specimens and participate in interviews, surveys, and participatory workshops or discussions as required by the study protocol.

Disqualifiers

Are temporary visitors without meaningful residence in the study communities.

Do not belong to the identified mobile or migrant populations targeted by the study.

Are unable or unwilling to provide the required biological specimens or participate in study procedures.

Decline informed consent or assent, or whose parent or guardian declines consent for participation.

Trial design

Treatments tested in this trial

  • Modified Mass Administration of Medicines Strategy
  • Albendazole 400 mg
  • Praziquantel 40 mg/kg
  • Ivermectin
  • Ivermectin + albendazole

Treatment groups

5,760 Participants
are divided into 1 treatment group

Sponsors and collaborators

Uwemedimo Friday Ekpo

Lead sponsor

Akwa Ibom State University, Ikot Akpaden, Nigeria

Sponsor institution

Mission To Save The Helpless

Collaborator

Marian University

Collaborator

Hellen Keller International

Collaborator

Nigerian Federal Ministry of Health

Collaborator